We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

06 March 2023
Semetron AS

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.

Vaata lähemalt

More news

Company news
Semetron is the official distributor of Anatomage in Estonia

We are pleased to announce that we are now the... View Article

Company news
The latest 3D mammography system is now installed at Viljandi Hospital

We are proud to have supplied and installed a latest-generation... View Article

Company news
News
BD Biosciences is now Waters Biosciences

Announcement!BD (Becton, Dickinson and Company) has merged its Biosciences division... View Article